Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Diagnostics (Basel) ; 13(11)2023 May 27.
Article in English | MEDLINE | ID: mdl-37296725

ABSTRACT

It is believed that fetal hemoglobin (HbF) expression in adults is largely genetically regulated. The increased expression of HbF in pregnancy has been reported in a small number of articles. Different mechanisms have been proposed, but the description of HbF expression during pregnancy remains unclear. The objectives of this study were to document HbF expression during peri and postpartum periods, confirm its maternal origin, and assess clinical and biochemical parameters potentially associated with HbF modulation. In this observational prospective study, 345 pregnant women were followed. At baseline, 169 had HbF expression (≥1% of total hemoglobin) and 176 did not have HbF expression. Women were followed at the obstetric clinic during their pregnancy. Clinical and biochemical parameters were measured at each visit. Analyses were made to determine which parameters had a significant correlation to HbF expression. Results show that HbF expression of ≥1% during peri and postpartum periods in pregnant women without influencing comorbidities is at its highest peak during the first trimester. In all women, it was proven that HbF was of maternal origin. A significant positive correlation between HbF expression, ßeta-human chorionic gonadotropin (ß-HCG), and glycosylated hemoglobin (HbA1c) was present. A significant negative association between HbF expression and total hemoglobin was found. HbF expression induction during pregnancy is probably associated with an increase in ß-HCG and HbA1C, and a decrease in total hemoglobin, which could temporarily reactivate the fetal erythropoietic system.

3.
Obstet Med ; 11(4): 195-197, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30574183

ABSTRACT

Henoch-Schonlein purpura is a relatively common pediatric vasculitis. Very few cases of Henoch-Schonlein purpura during pregnancy have been described. Henoch-Schonlein purpura is variable in its presentation, from completely benign to possibly catastrophic complications. This rarely encountered condition in adults can also be a recurrence of a previous childhood disease. We present a case of a pregnant 40-year-old woman with Henoch-Schonlein purpura, resulting in a viable birth with no fetal complications. Her presentation is discussed in detail and a general presentation of Henoch-Schonlein purpura is explored, with particular attention to its rare onset during pregnancy.

4.
Obstet Gynecol ; 127(4): 649-656, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26959206

ABSTRACT

OBJECTIVE: To evaluate the risk of pregnancy-associated venous thromboembolism in women with asymptomatic antithrombin deficiency. DATA SOURCES: The search was performed on MEDLINE (Ovid and PubMed databases) for the period 1966 to June 2012 and ClinicalTrials.gov as of December 15, 2015. METHODS OF STUDY SELECTION: A systematic review including randomized controlled trials, cohort studies, and case-control studies was conducted. Selection criteria included objectively diagnosed venous thromboembolism or venous thromboembolism treated with 3 months of anticoagulation before the availability of objective testing. The study population consisted of pregnant women with asymptomatic antithrombin deficiency. TABULATION, INTEGRATION, AND RESULTS: Seven publications were included in the review. No randomized controlled trials were identified. The best available data consist of three retrospective cohort studies and four case-control studies. Pooled results from case-control studies yielded an estimated odds ratio for venous thromboembolism of 6.09 (95% confidence interval 1.58-23.43). No pooled estimates could be obtained for cohort studies. Data on use of thromboprophylaxis were scarce. CONCLUSION: Despite the small number of patients included, and the variation in study designs, pooled results from case-control studies show a significant association between asymptomatic antithrombin deficiency and pregnancy-associated venous thromboembolism. Thromboprophylaxis during pregnancy and postpartum should be considered in these women.


Subject(s)
Antithrombin III Deficiency/complications , Asymptomatic Diseases , Pregnancy Complications, Cardiovascular/etiology , Venous Thromboembolism/etiology , Adult , Case-Control Studies , Female , Humans , Odds Ratio , Pregnancy , Pregnancy Complications, Cardiovascular/prevention & control , Retrospective Studies , Risk Factors , Venous Thromboembolism/prevention & control
5.
Obstet Med ; 8(4): 177-83, 2015 Dec.
Article in English | MEDLINE | ID: mdl-27512477

ABSTRACT

BACKGROUND: Severe headache during pregnancy is a challenging condition that may rarely imply endocrine disturbances. Rapid recognition of pituitary apoplexy is needed to improve pregnancy outcome. OBJECTIVE: To review and compare maternal and fetal outcomes after pituitary apoplexy. METHODS: Four cases of pituitary apoplexy during pregnancy in our centre are reported and literature review covering the past 54 years was performed. RESULTS: In the four cases presented and the 33 reported in the literature, most women presented with severe headaches and systemic symptoms. Overall, 42% were treated surgically, 31% received bromocriptine or cabergoline and 61% were given hormone replacement. No major obstetrical complication was reported and all babies were healthy. CONCLUSION: Pituitary apoplexy is a rare cause of sudden and severe headache during pregnancy. Rapid identification of this condition with potentially associated endocrine disturbances is important to ensure maternal and fetal well-being. A multidisciplinary team approach seems to reduce morbidity and mortality.

6.
Obstet Med ; 6(4): 172-4, 2013 Dec.
Article in English | MEDLINE | ID: mdl-27656252

ABSTRACT

A 30-year-old woman presented at 19 weeks of gestation with symptoms of sore throat, rhinorrhea and haemoptysis that progressed to massive haemoptysis. Her medical history included asthma and a history of smoking prior to pregnancy. Investigations revealed no obvious cause of bleeding. Right lower lobe lobectomy was performed, given the suspicion of a lesion within the intermediate bronchus. The patient developed adult respiratory distress syndrome around 36 h postoperatively. Polymerase chain reaction testing on bronchoalveolar lavage samples was positive for influenza A. Therapy with oseltamivir was initiated. She was discharged two weeks later. This is a rare case of a severe complication from seasonal interpandemic influenza during pregnancy, which underscores the importance of immunization for pregnant women.

7.
Obstet Gynecol ; 119(3): 617-25, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22353961

ABSTRACT

OBJECTIVE: Rupture of hepatic hematoma associated with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome is a catastrophic complication of pregnancy. Maternal and fetal mortality rates are still high despite advances in diagnosis and treatment. We aimed to present our experience at two referral centers for hepatic disease and to compare it with cases from the literature. METHODS: We reviewed nine cases that occurred over the past 6 years in our centers and made an extensive literature review covering the past 10 years. We reviewed and compared multiple outcomes for all these cases. RESULTS: The median maternal age of our patients was 29 years (interquartile range 27-32). Embolization treatment was used with seven of nine (78%) of our patients compared with 5 of 88 (6%) in the literature (P<.001). Our maternal and fetal mortality rates were 0% (95% confidence interval [CI] 0-34%) and 30% (95% CI 7-65%), respectively, compared with 17% (95% CI 10-26%) and 38% (95% CI 31-52%]) from our review of the literature from 2000 to 2010. CONCLUSION: The use of hepatic artery embolization to address hepatic rupture associated with HELLP syndrome may help minimize morbidity and maternal mortality.


Subject(s)
Embolization, Therapeutic , HELLP Syndrome/therapy , Hematoma/complications , Hemolysis , Liver Diseases/therapy , Pregnancy Complications, Hematologic/therapy , Adult , Blood Platelets , Female , Fetal Mortality , Hepatic Artery , Humans , Liver Diseases/diagnosis , Maternal Age , Maternal Mortality , Pregnancy , Pregnancy Complications, Hematologic/diagnosis , Rupture, Spontaneous/diagnosis , Rupture, Spontaneous/etiology , Rupture, Spontaneous/therapy , Young Adult
8.
Rev Synth ; 132(3): 325-49, 2011.
Article in French | MEDLINE | ID: mdl-21858620

ABSTRACT

This article offers a comparison of the legal suits filed by the interviewees against the director of the documentary Être et avoir (to have and to be) with the rights of interviewees in ethnographic investigations, focusing particularly on image copyrights and labor law. To say that interviewees contribute to such investigations in anonymity does not solve the main problem - they are crucial to the investigation, marginal to the analysis, and then are assigned no publication credits. While information about the interviewees should remain confidential, this article argues, that contribution and role in the making of a publication should not be ignored.


Subject(s)
Anthropology, Cultural/ethics , Anthropology, Cultural/legislation & jurisprudence , Copyright/legislation & jurisprudence , France , Humans , Motion Pictures/ethics , Motion Pictures/legislation & jurisprudence
SELECTION OF CITATIONS
SEARCH DETAIL
...